InvestorsHub Logo
icon url

boston745

07/28/18 11:00 PM

#17372 RE: boston745 #17371

Followup.

He who controls the stockprice controls the narrative and he who controls the narrative makes the money.

Everyone else just rides the rollarcoaster.
icon url

OhManIDied

07/29/18 10:41 PM

#17377 RE: boston745 #17371

Excellent analysis.. there's truly a remarkable opportunity here when you assess the facts as you did.

The science and product are nothing short of proven to be legit - this is not some speculative investment into a potentially superior solution.

The partnerships scream value as well and in normal cases, public disclosure is perceived very favorably and is subsequently reflected by a pop in the share price.

At this point I refuse to let go of what I'm holding. It really feels very close now after many years.

The extreme manipulation here is appalling and it is only possible because the wider market is not usurping control and setting the price based on the facts.

AMDA is currently being priced more unfairly than if it amounted to a preclinical long-shot miracle cure which is certain to be raising tons of capital through several rounds of financing for years of development with the possibility of heartache with a failure to meet the endpoint.

I don't believe the narrative that the share price is telling for a second. I'm very calmly and patiently holding and will add if my other play pops, hopefully this month.

OMID
icon url

Blutribe

07/30/18 12:53 PM

#17380 RE: boston745 #17371

Agreed with your post, AMDA undervalued at these levels given techg